Annual Report

Overview

The report presents Hansoh Pharma's 2019 ESG disclosure across operational compliance, product responsibility, employee development, resource use, pollution control, and community investment. It identifies 14 material topics and highlights approval of two national Category 1.1 innovative drugs and a workforce of 9,178 employees. The report also describes ISO9001 and ISO 14001 certifications, 5,239 anti-corruption-training participants, and RMB38.6608 million of funds and products donated to society.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Publication date: 30 March 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services